ResMed
RMD
$1.42 (0.67%)
1D
1W
3M
1Y
5Y
ALL
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 10 hours ago • RMD
What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 EarningsZacks Investment Research • 1 day ago • RMD
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 2 days ago • RMD
Here's Why ResMed (RMD) is a Strong Growth StockZacks Investment Research • 9 days ago • RMD
Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?Zacks Investment Research • 13 days ago • RMD
RMD Stock Benefits From the Launch of NightOwl Across USCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.